What is the Org number of Redsense Medical AB (publ)?

Redsense Medical AB (publ) is registered with Bolagsverket / SCB under Org 5566464862.

What is the revenue of Redsense Medical AB (publ)?

Redsense Medical AB (publ) reported revenue of SEK 21,7M in 2024.

Jennie Sofia Jeanette Kardell is Chief Executive Officer of Redsense Medical AB (publ), in role since 2024.

Eva Charlotta Walde chairs the board of Redsense Medical AB (publ), in role since 2024.

Redsense Medical AB (publ)'s registered address is Storgatan 36.

ABActive

Org 5566464862Storgatan 36, 302 43 HalmstadWholesale of pharmaceutical and medical goods · NACE 4646Est. 20035-9 employees

Actively employed in the business

Name	Role	Member since
Current (2)
SK Sebastien Kathleen Philippe Bollue Chief Executive Officer	Chief Executive Officer	2024
DA Dan Andreas Johansson Chief Auditor	Chief Auditor	2020
Former (4)
JS Jennie Sofia Jeanette Kardell Chief Executive Officer	Chief Executive Officer	2024 – 2024
JL Jan Lennart Carlsson Audit	Audit	2020 – 2021
NJ Nils Johan Pontus Nobréus Chief Executive Officer	Chief Executive Officer	2020 – 2024
KR Klas Rune Arildsson Chief Executive Officer	Chief Executive Officer	2020 – 2022

Non-executive oversight

Name	Role	Member since
Current (4)
JT Johannes Theophil Köpple	Board of Directors	2025
KE Karl Erik Martin Roos	Board of Directors	2024
SK Susanne Kerstin Anette Olausson	Chairman	2024
MS Michael Stephen Griffiths	Board of Directors	2025
Former (9)
AM Astrid Maria Alquist Hegbrant	Board of Directors	2022 – 2023
MA Malin Agneta Elisabeth Almgren	Board of Directors	2022 – 2025
LG Lena Gunilla Truedsson	Board of Directors	2020 – 2025
EC Eva Charlotta Walde	Chairman	2024 – 2024
PL Peter Lars Vilhelm Larsson	Board of Directors	2025 – 2025
LG Lars Gunnar Patrik Byhmer	Chairman	2022 – 2024
JB Jörgen Börje Albin Hegbrant	Board of Directors	2022 – 2023
BE Bo Erik Lennart Unéus	Chairman	2020 – 2022
AI Annette Ingegerd Marie Colin	Board of Directors	2022 – 2023

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.